XW Laboratories Inc., a Chinese biopharmaceutical research and development company focused on neurological disorders, has raised US$17.5 million in a series B financing led by Elements Capital and WI Harper. New investo KTB Network, and all existing investors KPCB China, Johnson & Johnson Innovation and WuXi Venture, also participated. This brings the total investment raised by XW Labs to US$23 million, which the company said it plans to utilize to continue the development of its multiple programs that are entering …

Elements Capital, WI Harper Lead $17.5M Series B Round In Chinese Biopharma Firm appeared first on China Money Network.